A CR in a couple of quarters is highly likely given the cash burn unless massive leaps are made in clocking revenue. So far, there is no sign of that happening.
At these levels there will be massive dilution.
- Forums
- ASX - By Stock
- 1TT
- Ann: Quarterly Appendix 4C and Commentary - 31 Mar 2016-RFN.AX
Ann: Quarterly Appendix 4C and Commentary - 31 Mar 2016-RFN.AX, page-249
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1TT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $611.6K |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 15726440 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 36004211 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 15716440 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 36004211 | 25 |
0.003 | 47622580 | 15 |
0.004 | 2865000 | 8 |
0.005 | 1090204 | 4 |
0.006 | 3000000 | 1 |
Last trade - 16.12pm 12/11/2024 (20 minute delay) ? |
Featured News
1TT (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online